Novartis Investigative Site

Kobe 650-0017

0 studies enrolling now · 5 studies all time

What they study most

Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC), Advanced Gastrointestinal Stromal Tumors (GIST), Advanced NRAS/BRAFT wt Cutaneous Melanoma, Chronic Myelogenous Leukemia, Chronic Spontaneous Urticaria, Esophageal Squamous Cell Cancer (SCC), Head/Neck SCC, KRAS G12-mutant NSCLC, Melanoma, Non-Small Cell Lung Cancer, Proliferative Diabetic Retinopathy

Studies at this site

• Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors — Stopped early
• Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy — Completed
• Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs — Completed
• A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early